6-56640591-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000370765.11(DST):c.431G>A(p.Arg144His) variant causes a missense change. The variant allele was found at a frequency of 0.0004 in 1,614,024 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R144C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000370765.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DST | NM_001374736.1 | c.2042G>A | p.Arg681His | missense_variant | 18/104 | ENST00000680361.1 | NP_001361665.1 | |
DST | NM_001723.7 | c.431G>A | p.Arg144His | missense_variant | 4/24 | ENST00000370765.11 | NP_001714.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DST | ENST00000680361.1 | c.2042G>A | p.Arg681His | missense_variant | 18/104 | NM_001374736.1 | ENSP00000505098 | |||
DST | ENST00000370765.11 | c.431G>A | p.Arg144His | missense_variant | 4/24 | 1 | NM_001723.7 | ENSP00000359801 |
Frequencies
GnomAD3 genomes AF: 0.000592 AC: 90AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000732 AC: 183AN: 250034Hom.: 0 AF XY: 0.000747 AC XY: 101AN XY: 135240
GnomAD4 exome AF: 0.000380 AC: 556AN: 1461768Hom.: 2 Cov.: 34 AF XY: 0.000400 AC XY: 291AN XY: 727194
GnomAD4 genome AF: 0.000591 AC: 90AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74440
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 08, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Reported using the transcript encoding the epithelial isoform of the gene - |
Hereditary sensory and autonomic neuropathy type 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DST-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 13, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at